Drugs Made In America Acquisition Corp. (DMAAU) Total Non-Current Liabilities (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Total Non-Current Liabilities came in at $6.9 million in Q4 2025.

Drugs Made In America Acquisition Corp. (DMAAU) Total Non-Current Liabilities (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of Total Non-Current Liabilities data on file, last reported at $6.9 million in Q4 2025.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (changed N/A YoY) and the FY2025 annual result came in at $6.9 million, changed N/A from the prior year.
Total Non-Current Liabilities held at $6.9 million in Q4 2025.
In the past five years, Total Non-Current Liabilities ranged from a high of $6.9 million in Q4 2025 to a low of $6.9 million in Q4 2025.

Download Data

Date	Value
Dec 31, 2025	6.90 Mn